在糖尿病中心理警
Sanjay Kalra1, Komal Verma2, Navneet Agrawal3
1Department of Endocrinology, Bharti Hospital, Karnal, India, University Center for Research & Development, Chandigarh University, India.
JPMA. The Journal of the Pakistan Medical Association
|November 28, 2023
概括
糖尿病患者经常面临心理健康问题,如抑郁症,这会使血糖控制恶化. 早期查,诊断和管理这些精神健康状况,称为心理警,对于更好的糖尿病护理至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
背景情况:
- 糖尿病经常伴随着各种心理健康障碍,包括抑郁症,焦虑症和药物滥用.
- 这些心理健康状况可能会对血糖控制和整体糖尿病管理产生负面影响.
- 糖尿病和心理健康之间的双向关系需要综合护理策略.
研究的目的:
- 介绍和定义心理警的概念.
- 强调查,早期诊断和糖尿病患者精神健康功能障碍及时管理的重要性.
- 倡导采取积极的方法来解决糖尿病护理中的心理健康负担.
主要方法:
- 关于糖尿病和心理健康的交叉点的文献综述.
- 心理警作为临床策略的概念化.
- 讨论对患者护理和结果的影响.
主要成果:
- 在糖尿病人群中,心理健康挑战很普遍.
- 心理健康不佳会加剧高血糖症,并使糖尿病管理复杂化.
- 心理警为综合护理提供了一个框架.
结论:
- 将心理健康查和管理纳入常规糖尿病护理是必不可少的.
- 心理警可以通过解决糖尿病的精神健康并发症来改善患者的治疗结果.
- 在心理健康功能障碍的早期干预是优化糖尿病控制的关键.
相关概念视频
Pharmacovigilance
850
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
850
Diabetes: Management and Pharmacotherapy
289
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
289
Diabetes: Symptoms, Diagnosis, and Complications
554
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
554
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Psychoneuroimmunology: Diabetes and Cancer
29
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
29
Insulin: Dosing Regimen and Adverse Effects
181
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
181


